PMI
Picard Medical, Inc.
9.40$
+7.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.6% | +0.3% | -2.4% | -0.4% | -1.2% | -2.2% | +15.5% | +66.8% | -50.2% | -18.3% | |
| – | +11.4% | +1.8% | -1.8% | +0.4% | -0.1% | -1.4% | +20.2% | +78.9% | -54.1% | -20.2% | |
| – | +68.0% | -81.0% | -92.3% | +1,500.0% | +616.7% | -40.4% | +586.1% | +164.9% | -98.4% | -68.6% | |
| – | +68.0% | -81.0% | -92.3% | +1,500.0% | +616.7% | -40.4% | +586.1% | +164.9% | -98.4% | -68.6% | |
| – | +28.7% | -16.6% | -21.2% | -0.3% | -81.0% | +1,086.6% | -17.6% | -34.9% | -21.3% | +3.0% | |
| – | +5.4% | +7.9% | +1.1% | +2.4% | -0.9% | -13.0% | -6.3% | +11.5% | +1.9% | -19.8% | |
| – | – | – | – | – | – | -10.5% | -11.8% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -3.2% | -3.3% | -3.4% | -3.6% | -3.7% | -3.7% | -4.0% | -4.1% | -4.3% | -4.5% | |
| – | +17.1% | +21.8% | +25.0% | +31.4% | +13.3% | +13.1% | -87.9% | +237.8% | -32.5% | -41.2% | |
| – | +32.0% | +54.7% | +41.4% | +32.8% | +13.8% | +13.5% | -88.2% | +247.9% | -32.3% | -41.1% | |
| – | +58.0% | +79.7% | +28.2% | +28.4% | +9.8% | -1.8% | -98.0% | +1,485.1% | -52.8% | -73.1% | |
| – | +2.7% | +24.7% | +28.9% | +3.9% | +4.3% | +15.4% | -51.0% | -33.4% | +30.4% | +22.6% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -52.4% | -138.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +22.4% | -38.3% | +35.3% | +1.0% | +24.7% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.